Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential

Abstract

The RON receptor tyrosine kinase is a member of the MET proto-oncogene family that has been implicated in regulating motile-invasive phenotypes in certain types of epithelial cancers. The purpose of this study was to determine if RON expression is altered in primary human colorectal adenocarcinomas. Results from immunohistochemical staining showed that RON is highly expressed in the majority of colorectal adenocarcinomas (29/49 cases). Accumulated RON is also constitutively active with autophosphorylation in tyrosine residues. Moreover, three splicing variants of RON, namely RONΔ165, RONΔ160, and RONΔ155 were detected and cloned from two primary colon cancer samples. These RON variants were generated by deletions in different regions in extracellular domains of the RON β chain. Functional studies showed that expression of RONΔ160 or RONΔ155 in Martin–Darby canine kidney cells resulted in increased cell dissociation (scatter-like activity). RON variants, RONΔ160 and RONΔ155, also exerted the ability to induce multiple focus formation and sustain anchorage-independent growth of transfected NIH3T3 cells. Moreover, NIH3T3 cells expressing RONΔ160 or RONΔ155 formed tumors in athymic nude mice and colonized in the lungs. These data suggest that RON expression is altered in certain primary colon cancers. Abnormal accumulation of RON variants may play a role in the progression of certain colorectal cancers in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  • Allred DC, Harvey JM, Berardo M and Clark GM . (1998). Mod. Pathol., 11, 155–168.

  • Angeloni D, Danilkovitch A, Ivanov SV, Breathnach R, Johnson BE, Leonard EJ and Lerman MI . (2000). Genes Chromosomes Cancer, 29, 147–156.

  • Birchmeier W, Brinkmann V, Niemann C, Meiners S, DiCesare S, Naundorf H and Sachs M . (1997). Ciba Found. Symp., 212, 230–240.

  • Chen Y-Q, Zhou Y-Q, Angeloni-Andreazzoli D, Kurtz AL, Qiang X-Z and Wang M-H . (2000). Exp. Cell Res., 261, 229–238.

  • Collesi C, Santoro MM, Gaudino G and Comoglio PM . (1996). Mol. Cell. Biol., 16, 5518–5526.

  • Comoglio PM, Tamagnone L and Boccaccio C . (1999). Exp. Cell Res., 253, 88–99.

  • Crawford JM . (1994). Pathological Basis of Disease: The Gastrointestinal Tract. Cotran RZ, Kumar V, Robbins SL (eds). WB Saunders: Philadelphia, PA, pp. 755–829.

    Google Scholar 

  • Dorudi S and Hart IR . (1993). Curr. Opin. Oncol., 5, 130–135.

  • Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ and Comoglio PM . (1994). EMBO J., 13, 3524–3532.

  • Greenlee RT, Murray T, Bolden S and Wingo PA . (2000). CA Cancer J. Clin., 50, 7–33.

  • Han S, Stuart LA and Degen SJF . (1991). Biochemistry, 30, 9768–9780.

  • Iwama A, Okano K, Sudo T, Matsuda Y and Suda T (1994). Blood, 83, 3160–3169.

  • Kinzler KW and Vogelstein B . (1998). The Genetic Basis of Human Cancer: Colorectal Tumors. Vogelstein B, Kinzler KW (eds). McGraw-Hill: New York, pp. 565–587.

    Google Scholar 

  • Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P and Comoglio PM . (1998). Oncogene, 16, 2927–2933.

  • Montero-Julian FA, Dauny I, Flavetta S, Ronsin C, Andre F, Xerri L, Wang M-H, Marvaldi J, Breathnach R and Brailly H . (1998). Hybridoma, 17, 541–551.

  • Okino T, Egami H, Ohmachi H, Takai E, Tamori Y, Nakagawa K, Nakano S, Akagi J, Sakamoto O, Suda T and Ogawa M . (1999). Int. J. Oncol., 13, 709–414.

  • Peace BE, Hughes MJ, Degen SJF and Waltz SE . (2001). Oncogene, 20, 6142–6151.

  • Porter AC and Vaillancourt RR . (1998). Oncogene, 17, 1343–1152.

  • Portera Jr CA, Berman RS and Ellis LM . (1988). Surg. Oncol., 7, 183–195.

  • Ronsin C, Muscatelli F, Mattei MG and Breathnach R . (1993). Oncogene, 8, 1195–1202.

  • Rubin JS, Bottaro DP and Aaronson SA . (1993). Biochem. Biophys. Acta, 1155, 357–364.

  • Santoro MM, Collesi C, Grisendi S, Gaudino G and Comoglio PM . (1996). Mol. Cell. Biol., 16, 7072–7083.

  • Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M and Gaudino G . (1998). Oncogene, 17, 741–749.

  • Skeel A, Yoshimura T, Showalter SD, Tanaka S, Appella E and Leonard EJ . (1991). J. Exp. Med., 173, 1227–1234.

  • Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I and Resau J . (1997). Ciba Found. Symp., 212, 119–130.

  • Wang M-H, Kurtz AL and Chen Y-Q . (2000). Carcinogenesis, 21, 1507–1512.

  • Wang M-H, Ronsin C, Gesnel MC, Coupeym L, Skeel A, Leonard EJ and Breathnach R . (1994a). Science, 266, 117–119.

  • Wang M-H, Yoshimura T, Skeel A and Leonard EJ . (1994b). J. Biol. Chem., 269, 3436–3440.

  • Williams TA, Longati P, Pugliese L, Gual P, Bardelli A and Michieli P . (1999). J. Cell. Physiol., 181, 507–514.

  • Xiao Z-Q, Chen Y-Q and Wang M-H . (2000). Biochem. Biophy. Res. Commun., 267, 669–675.

  • Yokota J . (1999). Carcinogenesis, 21, 497–503.

Download references

Acknowledgements

This work was performed in University of Colorado School of Medicine. We thank Drs EJ Leonard (National Cancer Institute of NIH, Frederick, MD, USA) for providing human MSP, G Gaudino (Universita di Torino, Novara, Italy) for RON-M1254T cDNA, and J Fisher (University of Colorado Health Sciences Center, Denver, CO, USA) for critical comments. We are grateful to Ms J Larson (Denver Health Medical Center, Denver, CO, USA) for editing the manuscript. The assistance from the staffs in the Department of Pathology at UCHSC and Denver Health Medical Center is greatly appreciated. This study was supported by NIH Grants R01 AI43516 and R01 CA91980 to MHW.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming-Hai Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, YQ., He, C., Chen, YQ. et al. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene 22, 186–197 (2003). https://doi.org/10.1038/sj.onc.1206075

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206075

Keywords

This article is cited by

Search

Quick links